
MiniMed Finalizes Board of Directors for Independent Future
Following its formal separation from Medtronic, Northridge-based diabetes technology firm MiniMed has finalized its nine-member board of directors. The newly appointed leadership aims to steer the independent public company toward expanded growth and streamlined innovation in insulin delivery, glucose sensing, and integrated software solutions for patients worldwide.


























